HighTower Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,759
Closed -$207K 3983
2026
Q1
$207K Sell
1,759
-1,677
-49% -$234K ﹤0.01% 3451
2025
Q4
$563K Buy
3,436
+529
+18% +$82.9K ﹤0.01% 2518
2025
Q3
$389K Sell
2,907
-911
-24% -$111K ﹤0.01% 2820
2025
Q2
$475K Sell
3,818
-2,010
-34% -$256K ﹤0.01% 2567
2025
Q1
$742K Buy
5,828
+774
+15% +$119K ﹤0.01% 2175
2024
Q4
$727K Sell
5,054
-180
-3% -$25.8K ﹤0.01% 2196
2024
Q3
$773K Sell
5,234
-788
-13% -$113K ﹤0.01% 2089
2024
Q2
$779K Sell
6,022
-18,050
-75% -$2.83M ﹤0.01% 2005
2024
Q1
$4.44M Sell
24,072
-1,205
-5% -$229K 0.01% 1021
2023
Q4
$4.57M Buy
25,277
+425
+2% +$66.2K 0.01% 1014
2023
Q3
$3.95M Buy
24,852
+140
+0.6% +$22.9K 0.01% 1031
2023
Q2
$3.5M Buy
24,712
+7,167
+41% +$1.15M 0.01% 1061
2023
Q1
$2.96M Sell
17,545
-762
-4% -$136K 0.01% 1088
2022
Q4
$3.12M Buy
18,307
+595
+3% +$108K 0.01% 1050
2022
Q3
$3.32M Buy
17,712
+210
+1% +$44.3K 0.01% 979
2022
Q2
$2.84M Sell
17,502
-150
-0.8% -$23.7K 0.01% 1066
2022
Q1
$3.33M Buy
17,652
+197
+1% +$37.4K 0.01% 1093
2021
Q4
$4.63M Sell
17,455
-375
-2% -$101K 0.01% 937
2021
Q3
$5.15M Buy
17,830
+1,116
+7% +$286K 0.01% 807
2021
Q2
$3.33M Sell
16,714
-59
-0.4% -$11.4K 0.01% 963
2021
Q1
$3.26M Sell
16,773
-664
-4% -$136K 0.01% 893
2020
Q4
$3.34M Buy
17,437
+308
+2% +$56K 0.01% 715
2020
Q3
$2.53M Buy
17,129
+2
+0% +$286 0.01% 796
2020
Q2
$2.12M Sell
17,127
-90
-0.5% -$10.6K 0.01% 792
2020
Q1
$1.66M Sell
17,217
-1,575
-8% -$152K 0.01% 811
2019
Q4
$1.73M Buy
18,792
+1,703
+10% +$143K 0.01% 908
2019
Q3
$1.31M Sell
17,089
-1,100
-6% -$96.2K 0.01% 1055
2019
Q2
$1.56M Sell
18,189
-44
-0.2% -$3K 0.01% 1004
2019
Q1
$1.08M Sell
18,233
-23
-0.1% -$1.32K 0.01% 1105
2018
Q4
$962K Sell
18,256
-448
-2% -$26.3K 0.01% 1057
2018
Q3
$1.04M Buy
18,704
+77
+0.4% +$3.97K 0.01% 1107
2018
Q2
$877K Hold
18,627
0.01% 1182
2018
Q1
$675K Buy
18,627
+300
+2% +$10.6K 0.01% 1287
2017
Q4
$665K Buy
18,327
+443
+2% +$16K 0.01% 1315
2017
Q3
$686K Buy
+17,884
New +$750K 0.01% 1281

Other funds holding RGEN

HighTower Advisors's RGEN Position: Q2 2026 in Review

HighTower Advisors sold out of Repligen (RGEN) in Q2 2026, closing a stake of 1,759 shares — an estimated $207K sold.

HighTower Advisors first reported a position in RGEN in Q3 2017 and held it in 35 quarters. The position peaked at $5.15M in Q3 2021. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • HighTower Advisors reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • HighTower Advisors sold 1,759 Repligen shares in Q2 2026, an estimated $207K.
  • HighTower Advisors first reported a position in Repligen in Q3 2017 and held it in 35 quarters.
  • HighTower Advisors's Repligen position peaked at $5.15M in Q3 2021.
  • 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.